Tag: Cancer: Rectal
Colorectal Cancer Risk Still Up in Patients With Ulcerative Colitis
Even after adjustment for tumor stage, patients with ulcerative colitis have higher risk for CRC mortality
Polygenic Risk Score More Strongly Linked to Early-Onset CRC
Strongest association seen for participants without a first-degree family history of colorectal cancer
Continuing Full Induction Regimen Not Beneficial in Metastatic CRC
Maintenance therapy shows benefit versus observation in terms of PFS but not overall survival
Treatment for Younger Adults With CRC Improved Under ACA
Timely receipt of adjuvant chemo more likely in DCE-eligible patients with resected stage IIB to IIIC CRC
CRC Screening Up for Ages 45 to 49 After ACS Guideline Update
Increase in screening rates in quarters 3, 4 of 2018 versus quarter 1; no change for people in their 50s
Four Studies Look at Global Burden of Digestive Diseases
Global burdens of colorectal, pancreatic, stomach cancers and inflammatory bowel disease examined
CRC Screening Recommended for Average-Risk Adults Age 50 to 75
CRC screening test should be selected based on discussion of benefits, harms, costs with patients
Personal Colorectal Cancer Risk Should Drive Screening
Panel issues weak recommendations for options in adults aged 50 to 79 years with no prior screening
Prediagnostic Colonoscopy Cuts Colorectal Cancer Death Risk
Mortality risk drops 17 percent with one colonoscopy before diagnosis, 45 percent with three colonoscopies
Triplet Tx Ups Survival in BRAF V600E-Mutated Colorectal Cancer
Overall survival longer for encorafenib, cetuximab, and binimetinib combo versus standard therapy
